This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

Hans van der Vliet, PhD, MD
medical oncologist and associate professor at Amsterdam UMC
Speaker

Profile

Hans van der Vliet, MD PhD is a medical oncologist and associate professor at the department of medical oncology of the Amsterdam UMC, VU University and Cancer Center Amsterdam and scientific founder and CSO of Lava Therapeutics B.V., a biotech company that develops proprietary Vγ9Vδ2 T-cell engagers.